Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/INNOVENT-BIOLOGICS-INC-49476402/actualite/Innovent-Biologics-Inc-annonce-que-le-premier-patient-a-recu-une-dose-dans-l-etude-de-phase-1-de-41236911/?utm_source=whatsapp&utm_medium=social&utm_campaign=share